Search clinical trials for: Rufinamide
Total 47 results
-
Zambon SpACompleted
-
Zambon SpAWithdrawnParkinson Disease | Dyskinesia, Drug-Induced
-
University of ZurichCompleted
-
Newron Pharmaceuticals SPAParexel; CliniRxCompleted
-
Newron Pharmaceuticals SPACompletedNeuropathic PainUnited Kingdom, Czech Republic, Poland, Italy, India, Austria
-
Alain KaelinClinical Trial Unit Ente Ospedaliero CantonaleRecruitingIdiopathic Parkinson's Disease (at Later Stage)Switzerland
-
Supernus Pharmaceuticals, Inc.CompletedIdiopathic Parkinson DiseaseUnited States
-
Eisai LimitedCompletedLennox-Gastaut SyndromeJapan
-
Wuhan Union Hospital, ChinaCompleted
-
Zambon SpACompletedIdiopathic Parkinson DiseaseSpain, Austria, Italy, Germany, France
-
Newron Pharmaceuticals SPACompleted
-
Newron Pharmaceuticals SPATerminatedParkinson's DiseaseRomania
-
CerRx, Inc.UnknownPeripheral T-cell LymphomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedHead and Neck CancerUnited States
-
Newron Pharmaceuticals SPACompletedHepatic ImpairmentGermany
-
Newron Pharmaceuticals SPATerminatedParkinson DiseaseUnited States
-
Newron Pharmaceuticals SPACompleted
-
Newron Pharmaceuticals SPACompletedParkinson's Disease With Cognitive ImpairmentsSpain, United States
-
SciTech Development, LLCRush University Medical CenterRecruitingMycosis Fungoides | Cutaneous T-cell Lymphoma | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T-cell Lymphoma | Cutaneous/Peripheral T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Classified | Primary Cutaneous T-cell Lymphoma | Cutaneous T-Cell Lymphoma, Unspecified | Follicular... and other conditionsUnited States
-
IRCCS San Raffaele RomaCompleted
-
Newron Pharmaceuticals SPACompleted
-
Newron Pharmaceuticals SPACompletedParkinson's DiseaseAustria, Canada, France, Germany, South Africa
-
Newron Pharmaceuticals SPACompleted
-
Eisai Inc.AvailableAn Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303Lennox Gastaut SyndromePoland
-
Eisai Korea Inc.Completed
-
Newron Pharmaceuticals SPATerminatedIdiopathic Parkinson's DiseaseSwitzerland
-
Eisai Co., Ltd.CompletedLennox-Gastaut SyndromeJapan
-
Eisai Co., Ltd.Completed
-
Eisai Inc.TerminatedRefractory Partial Onset SeizuresUnited States
-
Biotie Therapies Inc.Syneos HealthCompletedGeneralized Anxiety DisorderUnited States
-
Eisai Inc.CompletedEpilepsyUnited States
-
University of South AlabamaWithdrawnRefractory Partial SeizuresUnited States
-
Eisai Inc.CompletedLennox-Gastaut SyndromeFrance, Poland, United States, South Africa, Italy, Canada, Greece
-
University of ZurichWithdrawnPain | Peripheral Nerve InjuriesSwitzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Newron Pharmaceuticals SPACompletedIdiopathic Parkinson's DiseaseItaly
-
South Plains Oncology ConsortiumTerminatedOvarian Cancer | Cancer of the Ovary | Primary Peritoneal Carcinoma | Ovary Neoplasms | Cancer of OvaryUnited States
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaUnknown
-
South Plains Oncology ConsortiumTerminatedNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Zambon SpACross Research S.A.Completed
-
Cross Research S.A.Zambon SpACompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Newron Pharmaceuticals SPACompletedIdiopathic Parkinson's DiseaseUnited States, Spain, Brazil, Peru, Colombia, Germany, Argentina, India, Croatia, Czech Republic, Italy, South Africa, Finland, Portugal, Canada, Slovakia, Bulgaria, Chile, Mexico, Poland
-
University College, LondonThe Leeds Teaching Hospitals NHS Trust; Cambridge University Hospitals NHS... and other collaboratorsUnknown